Clinical study to evaluate the effect of Beam Fiel ointment on fungal skin conditions

Single-arm, open-label intervention study to investigate the efficacy of herbal fungicidal Beam Fiel ointment on fungal infections and skin conditions

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN87982460

Enrollment

140

Registered

2025-11-17

Start date

2025-12-15

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal skin infections Infections and Infestations

Interventions

This is a single-arm open-label clinical trial conducted among patients diagnosed with mild to moderate fungal skin infections. Eligible participants will apply Beamfiel ointment twice a day (morning

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male and female participants between the ages of 18–80 years 2. Participants with positive Potassium Hydroxide (KOH) mount test 3. Participants confirmed by KOH mount test with the fungal skin lesion of =3% of their Body Surface Area (BSA), except face and neck

Exclusion criteria

Exclusion criteria: 1. Individuals with hypersensitivity (type I, II, III and IV) to topical application 2. Individuals who are receiving any other local application for skin diseases 3. Immunocompromised individuals 4. Individuals with hypertension, diabetes mellitus and dyslipidemia 5. Individuals with chronic skin conditions like eczema, psoriasis, or dermatitis in the affected area 6. Individuals with secondary bacterial infections 7. Individuals in another clinical trial 8. Pregnant mothers, lactating mothers and children

Countries

Sri Lanka

Contacts

Public ContactSwarna Hapuarachchi

dr.sdhapuarachchi@fim.cmb.ac.lk+94 (0)714213832

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026